Nonsteroidal anti-inflammatory drug induced acute kidney injury; A review and case study

David Sabatino ¹ * , Michael Tillman ¹ , Jayne Pawasauskas ^1,2 , Todd Brothers ^1,3

Cited by CrossRef: 2

1- Yale A, So A, Guillén A, Desmas‐Bazelle I, Rogato F, Jepson R. Evaluation of Decreased Kidney Function in Dogs Receiving Carboplatin: A Retrospective Cohort Study of 98 Dogs (2006–2024). Vet Comparative Oncology. 2025;23(3):442 [Crossref]

2- Coșovanu E, Petroaie A, Cosmescu A, Coman A, Coșovanu E, Petroaie L, Tarțău L. FROM TOOTHACHE TO NEPHROPATHY: EXPLORING THE RENAL RISKS OF NON-STEROIDAL ANTI-INFLAMMATORY DRUGS IN DENTAL PRESCRIPTIONS. RJOR. 2025;17(2):851 [Crossref]

3- Pavani P, Naveena E, Subhashini P, Srikanth S, Naik K, Babu M. A Review on Non-Steroidal Anti-Inflammatory Drugs Induced Kidney Diseases. RJPPD. 2022;:268 [Crossref]

4- Kim D, Jeon Y, Kim H, Oh A, Ryu J, Bae Y, Koo C. Comparison between ketorolac- and fentanyl-based patient-controlled analgesia for acute kidney injury after robot-assisted radical prostatectomy: a retrospective propensity score-matched analysis. World J Urol. 2023;41(5):1437 [Crossref]

5- Doğan M, Deniz Doğan B. Acute Kidney Injury Induced by Non-Steroidal Anti-Inflammatory Drugs: A Case from Primary Care Outpatient Setting. Med Sci Discov. 2025;12(4):145 [Crossref]